nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CYP2E1—Dacarbazine—melanoma	0.121	0.256	CbGbCtD
Methotrimeprazine—CYP1A2—Carmustine—melanoma	0.116	0.244	CbGbCtD
Methotrimeprazine—CYP1A2—Vemurafenib—melanoma	0.0913	0.193	CbGbCtD
Methotrimeprazine—CYP2D6—Vemurafenib—melanoma	0.0753	0.159	CbGbCtD
Methotrimeprazine—CYP1A2—Dacarbazine—melanoma	0.07	0.148	CbGbCtD
Methotrimeprazine—DRD5—eyelid—melanoma	0.0223	0.335	CbGeAlD
Methotrimeprazine—Necrotising enterocolitis neonatal—Docetaxel—melanoma	0.0215	0.206	CcSEcCtD
Methotrimeprazine—Necrotizing enterocolitis—Docetaxel—melanoma	0.0215	0.206	CcSEcCtD
Methotrimeprazine—Necrotising colitis—Docetaxel—melanoma	0.0176	0.168	CcSEcCtD
Methotrimeprazine—CHRM5—skin epidermis—melanoma	0.00625	0.094	CbGeAlD
Methotrimeprazine—Photosensitivity—Vemurafenib—melanoma	0.00494	0.0472	CcSEcCtD
Methotrimeprazine—Liver injury—Temozolomide—melanoma	0.00363	0.0347	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Vemurafenib—melanoma	0.00342	0.0327	CcSEcCtD
Methotrimeprazine—Drug interaction—Carmustine—melanoma	0.00341	0.0326	CcSEcCtD
Methotrimeprazine—HTR2A—hindlimb—melanoma	0.00291	0.0437	CbGeAlD
Methotrimeprazine—HTR2A—appendage—melanoma	0.00249	0.0375	CbGeAlD
Methotrimeprazine—CHRM5—eye—melanoma	0.00223	0.0335	CbGeAlD
Methotrimeprazine—Drug interaction—Docetaxel—melanoma	0.00219	0.0209	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Docetaxel—melanoma	0.00203	0.0194	CcSEcCtD
Methotrimeprazine—CHRM5—skin of body—melanoma	0.00194	0.0291	CbGeAlD
Methotrimeprazine—Constipation—Vemurafenib—melanoma	0.00182	0.0174	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Dactinomycin—melanoma	0.00176	0.0169	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Temozolomide—melanoma	0.00175	0.0167	CcSEcCtD
Methotrimeprazine—Weight increased—Temozolomide—melanoma	0.00174	0.0167	CcSEcCtD
Methotrimeprazine—CHRM4—head—melanoma	0.00162	0.0243	CbGeAlD
Methotrimeprazine—Hypersensitivity—Vemurafenib—melanoma	0.00157	0.015	CcSEcCtD
Methotrimeprazine—HTR2A—endothelium—melanoma	0.00151	0.0226	CbGeAlD
Methotrimeprazine—DRD3—head—melanoma	0.0015	0.0226	CbGeAlD
Methotrimeprazine—DRD5—head—melanoma	0.00141	0.0212	CbGeAlD
Methotrimeprazine—HTR2A—blood vessel—melanoma	0.00139	0.0209	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Docetaxel—melanoma	0.00135	0.0129	CcSEcCtD
Methotrimeprazine—CHRM5—head—melanoma	0.00126	0.019	CbGeAlD
Methotrimeprazine—Weight increased—Docetaxel—melanoma	0.00116	0.0111	CcSEcCtD
Methotrimeprazine—ADRA1B—head—melanoma	0.00115	0.0174	CbGeAlD
Methotrimeprazine—ADRA1D—head—melanoma	0.00113	0.017	CbGeAlD
Methotrimeprazine—DRD2—eye—melanoma	0.00112	0.0168	CbGeAlD
Methotrimeprazine—DRD2—retina—melanoma	0.00111	0.0167	CbGeAlD
Methotrimeprazine—Jaundice—Docetaxel—melanoma	0.00111	0.0106	CcSEcCtD
Methotrimeprazine—Tachycardia—Carmustine—melanoma	0.0011	0.0105	CcSEcCtD
Methotrimeprazine—DRD1—head—melanoma	0.00108	0.0162	CbGeAlD
Methotrimeprazine—Agranulocytosis—Docetaxel—melanoma	0.00106	0.0101	CcSEcCtD
Methotrimeprazine—Somnolence—Carmustine—melanoma	0.001	0.00958	CcSEcCtD
Methotrimeprazine—HTR2A—neck—melanoma	0.000993	0.0149	CbGeAlD
Methotrimeprazine—Somnolence—Temozolomide—melanoma	0.000969	0.00926	CcSEcCtD
Methotrimeprazine—Constipation—Carmustine—melanoma	0.000964	0.00922	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Bleomycin—melanoma	0.000952	0.0091	CcSEcCtD
Methotrimeprazine—Constipation—Temozolomide—melanoma	0.000932	0.00891	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Dactinomycin—melanoma	0.000887	0.00849	CcSEcCtD
Methotrimeprazine—HRH1—eye—melanoma	0.000884	0.0133	CbGeAlD
Methotrimeprazine—CHRM2—head—melanoma	0.000867	0.013	CbGeAlD
Methotrimeprazine—ADRA2C—mammalian vulva—melanoma	0.000864	0.013	CbGeAlD
Methotrimeprazine—HTR2C—head—melanoma	0.000836	0.0126	CbGeAlD
Methotrimeprazine—Hypersensitivity—Carmustine—melanoma	0.000831	0.00794	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Temozolomide—melanoma	0.000803	0.00767	CcSEcCtD
Methotrimeprazine—CHRM1—head—melanoma	0.000789	0.0119	CbGeAlD
Methotrimeprazine—HTR2A—eye—melanoma	0.000739	0.0111	CbGeAlD
Methotrimeprazine—HTR2A—retina—melanoma	0.000732	0.011	CbGeAlD
Methotrimeprazine—Tachycardia—Docetaxel—melanoma	0.000707	0.00676	CcSEcCtD
Methotrimeprazine—CHRM3—head—melanoma	0.000706	0.0106	CbGeAlD
Methotrimeprazine—HRH1—mammalian vulva—melanoma	0.000702	0.0106	CbGeAlD
Methotrimeprazine—ADRA2A—mammalian vulva—melanoma	0.000689	0.0104	CbGeAlD
Methotrimeprazine—ADRA1A—head—melanoma	0.000649	0.00976	CbGeAlD
Methotrimeprazine—Somnolence—Docetaxel—melanoma	0.000644	0.00616	CcSEcCtD
Methotrimeprazine—DRD2—head—melanoma	0.000636	0.00956	CbGeAlD
Methotrimeprazine—Constipation—Docetaxel—melanoma	0.00062	0.00592	CcSEcCtD
Methotrimeprazine—ADRA2C—head—melanoma	0.000618	0.0093	CbGeAlD
Methotrimeprazine—Hypersensitivity—Docetaxel—melanoma	0.000534	0.0051	CcSEcCtD
Methotrimeprazine—HRH1—head—melanoma	0.000502	0.00755	CbGeAlD
Methotrimeprazine—ADRA2A—head—melanoma	0.000493	0.00742	CbGeAlD
Methotrimeprazine—CYP2E1—head—melanoma	0.000482	0.00726	CbGeAlD
Methotrimeprazine—ADRA2C—lymph node—melanoma	0.000433	0.00651	CbGeAlD
Methotrimeprazine—HTR2A—head—melanoma	0.000419	0.00631	CbGeAlD
Methotrimeprazine—CYP2D6—head—melanoma	0.000382	0.00575	CbGeAlD
Methotrimeprazine—HRH1—lymph node—melanoma	0.000352	0.00529	CbGeAlD
Methotrimeprazine—ADRA2A—lymph node—melanoma	0.000345	0.00519	CbGeAlD
Methotrimeprazine—Diltiazem—ABCB1—melanoma	0.000143	0.0999	CrCbGaD
Methotrimeprazine—Triflupromazine—ABCB1—melanoma	0.000127	0.089	CrCbGaD
Methotrimeprazine—Acepromazine—ALB—melanoma	0.000123	0.0863	CrCbGaD
Methotrimeprazine—Thioproperazine—ALB—melanoma	0.00012	0.0844	CrCbGaD
Methotrimeprazine—Pipotiazine—ALB—melanoma	0.000118	0.083	CrCbGaD
Methotrimeprazine—Fluphenazine—ABCB1—melanoma	9.77e-05	0.0685	CrCbGaD
Methotrimeprazine—Clomipramine—ALB—melanoma	9.36e-05	0.0656	CrCbGaD
Methotrimeprazine—Clomipramine—ABCB1—melanoma	8.94e-05	0.0626	CrCbGaD
Methotrimeprazine—Chlorprothixene—ABCB1—melanoma	8.9e-05	0.0623	CrCbGaD
Methotrimeprazine—Trimipramine—ABCB1—melanoma	8.22e-05	0.0576	CrCbGaD
Methotrimeprazine—Promethazine—ABCB1—melanoma	7.92e-05	0.0555	CrCbGaD
Methotrimeprazine—Trifluoperazine—ABCB1—melanoma	7.81e-05	0.0547	CrCbGaD
Methotrimeprazine—Chlorpromazine—ALB—melanoma	6.42e-05	0.045	CrCbGaD
Methotrimeprazine—Chlorpromazine—ABCB1—melanoma	6.13e-05	0.043	CrCbGaD
Methotrimeprazine—Imipramine—ABCB1—melanoma	6.1e-05	0.0427	CrCbGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCL8—melanoma	6.77e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—melanoma	6.77e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NFKB1—melanoma	6.77e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CTNNB1—melanoma	6.74e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—melanoma	6.74e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—melanoma	6.73e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HRAS—melanoma	6.73e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	6.73e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—melanoma	6.72e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDKN1A—melanoma	6.71e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—STAT3—melanoma	6.71e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—melanoma	6.7e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDKN1A—melanoma	6.7e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PTEN—melanoma	6.7e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NRAS—melanoma	6.69e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTEN—melanoma	6.69e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PTEN—melanoma	6.68e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—melanoma	6.68e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDKN1A—melanoma	6.67e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PIK3CA—melanoma	6.67e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MYC—melanoma	6.67e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—melanoma	6.67e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NFKB1—melanoma	6.66e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PTEN—melanoma	6.66e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDKN1A—melanoma	6.65e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NFKB1—melanoma	6.65e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—melanoma	6.64e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PTEN—melanoma	6.64e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NFKB1—melanoma	6.63e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	6.62e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—melanoma	6.61e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NFKB1—melanoma	6.61e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—STAT3—melanoma	6.6e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—melanoma	6.59e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDKN1A—melanoma	6.59e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK3—melanoma	6.59e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NRAS—melanoma	6.58e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PTEN—melanoma	6.57e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	6.57e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PTEN—melanoma	6.56e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	6.54e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NFKB1—melanoma	6.54e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HRAS—melanoma	6.53e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—melanoma	6.53e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK1—melanoma	6.53e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EGFR—melanoma	6.53e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NFKB1—melanoma	6.52e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—melanoma	6.52e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—melanoma	6.5e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CASP3—melanoma	6.48e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—melanoma	6.48e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2—melanoma	6.47e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—melanoma	6.45e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HRAS—melanoma	6.45e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—melanoma	6.44e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—melanoma	6.41e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK3—melanoma	6.41e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MYC—melanoma	6.41e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—melanoma	6.4e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.37e-06	1.8e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PIK3CA—melanoma	6.36e-06	1.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PIK3CA—melanoma	6.33e-06	1.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCND1—melanoma	6.31e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK3—melanoma	6.31e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CD—melanoma	6.3e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PIK3CA—melanoma	6.27e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	6.27e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK1—melanoma	6.27e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EGFR—melanoma	6.27e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—melanoma	6.25e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	6.25e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MYC—melanoma	6.23e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—melanoma	6.22e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HRAS—melanoma	6.17e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—melanoma	6.17e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—KRAS—melanoma	6.16e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—melanoma	6.15e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—melanoma	6.15e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MYC—melanoma	6.13e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—melanoma	6.13e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	6.1e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK1—melanoma	6.1e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EGFR—melanoma	6.1e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PTEN—melanoma	6.09e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—STAT3—melanoma	6.09e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CG—melanoma	6.07e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NRAS—melanoma	6.07e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—melanoma	6.07e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—melanoma	6.07e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NFKB1—melanoma	6.06e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—melanoma	6.05e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—melanoma	6.03e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—melanoma	6.01e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK1—melanoma	6e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EGFR—melanoma	6e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—melanoma	6e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—STAT3—melanoma	5.99e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—STAT3—melanoma	5.97e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NRAS—melanoma	5.97e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NRAS—melanoma	5.96e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—STAT3—melanoma	5.96e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—melanoma	5.94e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NRAS—melanoma	5.94e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—melanoma	5.94e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—STAT3—melanoma	5.94e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NRAS—melanoma	5.92e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—melanoma	5.92e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—KRAS—melanoma	5.92e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—melanoma	5.91e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HRAS—melanoma	5.88e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—STAT3—melanoma	5.88e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NRAS—melanoma	5.86e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—STAT3—melanoma	5.86e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—melanoma	5.86e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NRAS—melanoma	5.85e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK3—melanoma	5.81e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HRAS—melanoma	5.8e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HRAS—melanoma	5.8e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—melanoma	5.77e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—KRAS—melanoma	5.76e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK3—melanoma	5.72e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK3—melanoma	5.71e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—melanoma	5.69e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK3—melanoma	5.69e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK3—melanoma	5.67e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—KRAS—melanoma	5.67e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	5.66e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MYC—melanoma	5.65e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—melanoma	5.63e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK3—melanoma	5.62e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK3—melanoma	5.6e-06	1.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PIK3CA—melanoma	5.6e-06	1.58e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MYC—melanoma	5.56e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—melanoma	5.55e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—melanoma	5.55e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MYC—melanoma	5.55e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MYC—melanoma	5.53e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK1—melanoma	5.53e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EGFR—melanoma	5.53e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MYC—melanoma	5.52e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—melanoma	5.5e-06	1.55e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CB—melanoma	5.49e-06	1.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—melanoma	5.48e-06	1.55e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MYC—melanoma	5.46e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—melanoma	5.45e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MYC—melanoma	5.45e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—STAT3—melanoma	5.45e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK1—melanoma	5.44e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—melanoma	5.44e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EGFR—melanoma	5.44e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PIK3CA—melanoma	5.44e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NRAS—melanoma	5.43e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK1—melanoma	5.43e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EGFR—melanoma	5.43e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK1—melanoma	5.41e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EGFR—melanoma	5.41e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK1—melanoma	5.4e-06	1.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EGFR—melanoma	5.4e-06	1.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK1—melanoma	5.34e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EGFR—melanoma	5.34e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CD—melanoma	5.34e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK1—melanoma	5.33e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EGFR—melanoma	5.33e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	5.29e-06	1.49e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—melanoma	5.27e-06	1.49e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—melanoma	5.26e-06	1.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HRAS—melanoma	5.24e-06	1.48e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—KRAS—melanoma	5.22e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	5.21e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK3—melanoma	5.2e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—melanoma	5.19e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—melanoma	5.17e-06	1.46e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—KRAS—melanoma	5.14e-06	1.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PIK3CA—melanoma	5.14e-06	1.45e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—KRAS—melanoma	5.13e-06	1.45e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—melanoma	5.12e-06	1.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—melanoma	5.12e-06	1.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—melanoma	5.12e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—KRAS—melanoma	5.11e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—KRAS—melanoma	5.1e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MYC—melanoma	5.06e-06	1.43e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—KRAS—melanoma	5.05e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—melanoma	5.04e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—KRAS—melanoma	5.03e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HRAS—melanoma	5.03e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—melanoma	5.02e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK1—melanoma	4.95e-06	1.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EGFR—melanoma	4.95e-06	1.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HRAS—melanoma	4.89e-06	1.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HRAS—melanoma	4.82e-06	1.36e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—melanoma	4.82e-06	1.36e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CA—melanoma	4.8e-06	1.35e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTEN—melanoma	4.75e-06	1.34e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CA—melanoma	4.72e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CA—melanoma	4.72e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CA—melanoma	4.71e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CA—melanoma	4.7e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—melanoma	4.68e-06	1.32e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CA—melanoma	4.68e-06	1.32e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—KRAS—melanoma	4.68e-06	1.32e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CB—melanoma	4.65e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—melanoma	4.64e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CA—melanoma	4.64e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—melanoma	4.63e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	4.62e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—melanoma	4.61e-06	1.3e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—melanoma	4.61e-06	1.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—melanoma	4.58e-06	1.29e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—melanoma	4.57e-06	1.29e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—melanoma	4.56e-06	1.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—melanoma	4.54e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—melanoma	4.53e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—melanoma	4.49e-06	1.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—melanoma	4.47e-06	1.26e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—melanoma	4.44e-06	1.25e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HRAS—melanoma	4.44e-06	1.25e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—HRAS—melanoma	4.37e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HRAS—melanoma	4.36e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HRAS—melanoma	4.35e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HRAS—melanoma	4.33e-06	1.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—melanoma	4.32e-06	1.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	4.3e-06	1.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HRAS—melanoma	4.29e-06	1.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HRAS—melanoma	4.28e-06	1.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—melanoma	4.25e-06	1.2e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—melanoma	4.25e-06	1.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—melanoma	4.2e-06	1.18e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—melanoma	4.18e-06	1.18e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—melanoma	4.17e-06	1.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—melanoma	4.16e-06	1.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—melanoma	4.16e-06	1.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—melanoma	4.15e-06	1.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—melanoma	4.11e-06	1.16e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—melanoma	4.1e-06	1.16e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTEN—melanoma	4.02e-06	1.13e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HRAS—melanoma	3.98e-06	1.12e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—melanoma	3.92e-06	1.11e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—melanoma	3.86e-06	1.09e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—melanoma	3.86e-06	1.09e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—melanoma	3.85e-06	1.09e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—melanoma	3.84e-06	1.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—melanoma	3.83e-06	1.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—melanoma	3.81e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—melanoma	3.79e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—melanoma	3.78e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—melanoma	3.51e-06	9.91e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CA—melanoma	3.35e-06	9.45e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CA—melanoma	2.84e-06	8.01e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—melanoma	2.74e-06	7.72e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—melanoma	2.32e-06	6.54e-06	CbGpPWpGaD
